SPAST and Spastic paraplegia: This demonstrates a rapid, non-invasive, and inexpensive test for recognizing the SPG4 hereditary spastic paraplegia subtype and evaluating the effects of spastin-enhancing drugs in non-neuronal cells (Figure 2).